10-K: Health Catalyst Reports Annual Results, Navigates Macroeconomic Headwinds

Health Catalyst's 2024 10-K filing reveals a year of revenue growth amidst ongoing macroeconomic challenges and strategic restructuring.

Summary

• Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, filed its annual report on Form 10-K for the fiscal year ended December 31, 2024.
• The company's solution comprises a cloud-based data platform, software applications, and expertise, enabling healthcare providers to manage data and derive analytical insights.
• Total revenue for 2024 reached $306.6 million, an increase from $295.9 million in 2023 and $276.2 million in 2022.
• Despite revenue growth, the company reported a net loss of $69.5 million for 2024, compared to net losses of $118.1 million in 2023 and $137.4 million in 2022.
• Adjusted EBITDA for 2024 was $26.1 million, a significant increase from $11.0 million in 2023 and $(2.5) million in 2022.
• The company is actively migrating clients to its Health Catalyst Ignite platform and has an attractive operating model due to the recurring nature of its revenue.
• Health Catalyst is focusing on expanding within its current client base and adding new applications and offerings.
• The company's dollar-based retention rate for platform clients was 100% for each of the years ended December 31, 2024, 2023, and 2022.
• The company is subject to extensive and complex federal and state laws and regulations, including data privacy and security laws and fraud, waste, and abuse regulations.
• As of December 31, 2024, the company had more than 1,500 team members.
• The company completed acquisitions of Carevive, Lumeon, and Intraprise in 2024 and Upfront in January 2025 to expand its solution offerings.
• The company has a five-year term loan facility with Silver Point Finance, with an aggregate principal amount of up to $225 million.
• The company is exposed to interest rate risks with regard to its Term Loan Facility and any future refinancing thereof.
• The company is committed to ensuring team members receive equal pay for equal work.

Sentiment

Score: 7

Explanation: The document presents a mixed picture. While revenue is growing and Adjusted EBITDA is improving, the company is still operating at a loss. The company is taking steps to improve its financial performance, but there are still risks and uncertainties.

Positives

• Revenue growth indicates increasing market adoption of Health Catalyst's solutions.
• Significant improvement in Adjusted EBITDA suggests enhanced operational efficiency and profitability.
• High dollar-based retention rate demonstrates strong client loyalty and recurring revenue.
• Strategic acquisitions expand the company's product portfolio and market reach.
• The company's leadership team is committed to team member engagement.

Negatives

• The company reported a net loss of $69.5 million for 2024, indicating ongoing challenges with profitability.
• The company is exposed to interest rate risks with regard to its Term Loan Facility and any future refinancing thereof.

Risks

• The company operates in a highly competitive industry and faces competition from various types of companies.
• Macroeconomic challenges, including high inflation and interest rates, could harm the company's business and financial condition.
• The company may be unable to successfully execute its growth initiatives and cost reduction plans.
• The company's solution may not operate properly, which could damage its reputation and lead to claims.
• The company's increasing reliance on AI and machine learning technologies may expose it to significant risks.
• The company is subject to extensive and complex government regulations, including data privacy and security laws.
• The company's ability to use its net operating losses to offset future taxable income may be subject to certain limitations.

Future Outlook

The company expects to continue growing its client base, expanding within its current client base, and adding new applications and offerings. The company anticipates net new Platform Clients additions will have an aggregated average total ARR and non-recurring revenue range of $300,000 and $700,000 in 2025.

Management Comments

• The team member experience is the #1 priority of our CEO and other members of our leadership team.
• Our focus on multiple channels, as well as our collaborative company culture, results in high levels of sustainable growth.

Industry Context

The healthcare industry is characterized by waste, changing economics, and data complexity, making analytics-driven decision-making crucial for success. The increasing market share of EHR companies in data analytic services at hospital systems may cause our existing clients to terminate contracts with us in order to engage EHR companies to provide these services.

Comparison to Industry Standards

• The company competes with industry-agnostic analytics companies like IBM, Databricks, and Snowflake.
• The company also competes with EHR companies like Oracle Health and Epic Systems.
• Point solution companies such as Optum Analytics, Premier, and Arcadia.io are also competitors.
• The company's KLAS Overall Customer Satisfaction Scores have often historically been among the highest in the peer group.

Related Party Transactions

• The company has entered into arrangements with a client, Carle Health, and a member of the client's executive leadership team began serving on the company's board of directors effective July 1, 2023.
• The company recognized revenue from this related party of $16.7 million and $8.1 million for the years ended December 31, 2024 and 2023, respectively, after the related party relationship commenced.
• As of December 31, 2024 and 2023, the company had receivables from this related party of $2.2 million and $1.9 million, respectively, and deferred revenue with this related party of $0.1 million and $0.1 million, respectively.

Stakeholder Impact

• The company's performance impacts shareholders, employees, customers, suppliers, and creditors.
• The company is committed to building and maintaining a remarkable culture that benefits its clients, team members, and other stakeholders.

Next Steps

• The company will hold its annual Health Catalyst Analytics Summit (HAS) in August 2025.
• The company will continue to monitor migrations from DOS to Ignite.
• The company will continue to refine its strategic operating plan and are continuing to make several investments in research and development, primarily in enhancing the capabilities within Health Catalyst Ignite, in order to maintain our position as a market-leading data platform over the long term.

Key Dates